Volume 9, Number 1—January 2003
Research
Cost Effectiveness of a Potential Vaccine for Human papillomavirus
Figure 4
![Sensitivity analysis: Vaccine cost. Effect of a change in Human papillomavirus (HPV) vaccine cost on the cost effectiveness of vaccination compared with current practice under varying assumptions of vaccine immunity. The triangles represent a vaccine that provides lifetime immunity to high-risk types of HPV. The circles represent a vaccine that requires booster shots every 10 years to remain effective (base-case assumption). The hatches represent a vaccine that requires booster shots every 5 yea](/eid/images/02-0168-F4.jpg)
Figure 4. Sensitivity analysis: Vaccine cost. Effect of a change in Human papillomavirus (HPV) vaccine cost on the cost effectiveness of vaccination compared with current practice under varying assumptions of vaccine immunity. The triangles represent a vaccine that provides lifetime immunity to high-risk types of HPV. The circles represent a vaccine that requires booster shots every 10 years to remain effective (base-case assumption). The hatches represent a vaccine that requires booster shots every 5 years to remain effective. The dashed line indicates the $50,000 per quality-adjusted life year cost-effectiveness threshold. The base-case value of $300 is indicated by the arrow.
Page created: December 07, 2010
Page updated: December 07, 2010
Page reviewed: December 07, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.